References
- TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
- VenookAPPapandreouCFuruseJde GuevaraLLThe incidence and epidemiology of hepatocellular carcinoma: a global and regional perspectiveOncologist201015Suppl 4513
- SemelkaRCHelmbergerTKContrast agents for MR imaging of the liverRadiology20012181273811152776
- CruiteISchroederMMerkleEMSirlinCBGadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liverAJR Am J Roentgenol20101951294120566795
- TanWDonovanMJJiangJAptamers from cell-based selection for bioanalytical applicationsChem Rev201311342842286223509854
- KangWJLeeJLeeYSMultimodal imaging probe for targeting cancer cells using uMUC-1 aptamerColloids Surf B Biointerfaces201513613414026387066
- JinCZhengJLiCQiuLZhangXTanWAptamers selected by cell-SELEX for molecular imagingJ Mol Evol2015815–616217126584804
- LibbrechtLSeveriTCassimanDGlypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodulesAm J Surg Pathol200630111405141117063081
- WangXYDegosFDuboisSGlypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomasHum Pathol200637111435144116949914
- YamauchiNWatanabeAHishinumaMThe glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinomaMod Pathol200518121591159815920546
- HaruyamaYKataokaHGlypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinomaWorld J Gastroenterol201622127528326755876
- HsuHCChengWLaiPLCloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distributionCancer Res19975722517951849371521
- CapurroMWanlessIRShermanMGlypican-3: a novel serum and histochemical marker for hepatocellular carcinomaGastroenterology20031251899712851874
- ZhaoMDongLLiuZYangSWuWLinJIn vivo fluorescence imaging of hepatocellular carcinoma using a novel GPC3-specific aptamer probeQuant Imaging Med Surg20188215116029675356
- Di MarcoMSadunCPortMGuilbertICouvreurPDubernetCPhysicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agentsInt J Nanomedicine20072460962218203428
- LeeNYooDLingDChoMHHyeonTCheonJIron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapyChem Rev201511519106371068926250431
- LiYChenZLiFWangJZhangZPreparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinomaInt J Nanomedicine201274593461122956868
- YuMKKimDLeeIHSoJSJeongYYJonSImage-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticlesSmall20117152241224921648076
- YouXGTuRPengMLMolecular magnetic resonance probe targeting VEGF165: preparation and in vitro and in vivo evaluationContrast Media Mol Imaging20149534935424729581
- ZhangLHeRGuHOleic acid coating on the monodisperse magnetite nanoparticlesAppl Surf Sci2006253526112617
- McDermottSKilcoyneAMolecular imaging – its current role in cancerQJM2016109529529926253299
- McMahonMTChanKWDeveloping MR probes for molecular imagingAdv Cancer Res201412429732725287693
- WangYXIdeeJMA comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imagingQuant Imaging Med Surg2017718812228275562
- JacobsonOWeissIDWangL18F-labeled single-stranded DNA aptamer for PET imaging of protein tyrosine kinase-7 expressionJ Nucl Med201556111780178526315836
- ShiHHeXWangKActivatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alterationProc Natl Acad Sci U S A2011108103900390521368158
- HwangDWKoHYLeeJHA nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamerJ Nucl Med20105119810520008986
- RoyKKanwarRKKanwarJRLNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imagingBiomaterials201571849926318819
- LeiCJYaoCPanQYLentivirus vectors construction of SiRNA targeting interference GPC3 gene and its biological effects on liver cancer cell lines Huh-7Asian Pac J Trop Med201471078078625129460
- MosaferJAbnousKTafaghodiMMokhtarzadehARamezaniMIn vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapyEur J Pharm Biopharm2017113607428012991
- WeiZWuYZhaoYMultifunctional nanoprobe for cancer cell targeting and simultaneous fluorescence/magnetic resonance imagingAnal Chim Acta201693815616427619098
- WuLMendoza-GarciaALiQSunSOrganic phase syntheses of magnetic nanoparticles and their applicationsChem Rev201611618104731051227355413